(Q34990088)

5 August 2017

1 reference

title

Pulmonary-renal syndromes in the intensive care unit (English)

1 reference

5 August 2017

1 reference

2

Nicola Hanania

1 reference

5 August 2017

William Rodriguez

1

1 reference

PubMed ID

12418445

5 August 2017

Elizabeth Guy

series ordinal

3

1 reference

PubMed ID

12418445

5 August 2017

Jayarama Guntupalli

series ordinal

4

1 reference

5 August 2017

1 October 2002

1 reference

5 August 2017

Critical Care Clinics

1 reference

5 August 2017

18

1 reference

5 August 2017

4

1 reference

5 August 2017

881-95, x

1 reference

THE SIGNIFICANCE OF CERTAIN PULMONARY LESIONS IN RELATION TO THE ETIOLOGY OF INFLUENZA

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

The alpha 3 chain of type IV collagen induces autoimmune Goodpasture syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Goodpasture syndrome: molecular and clinical advances.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Goodpasture's syndrome with normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Goodpasture's Syndrome Associated with Influenza A2 Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Glomerulonephritis associated with hydrocarbon solvents: mediated by antiglomerular basement membrane antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Goodpasture's syndrome. Unusual presentation after exposure to hard metal dust

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Surgical pathology of the lung in anti-basement membrane antibody-associated Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Time course of hemosiderin production by alveolar macrophages in a murine model.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Diagnostic value of hemosiderin-containing macrophages in bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Human macrophage hemoglobin-iron metabolism in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

The chest x-ray in antiglomerular basement membrane antibody disease (Goodpasture's syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Detection of intrapulmonary hemorrhage with carbon monoxide uptake. Application in goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Monitoring intrapulmonary hemorrhage in Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Immunohistopathology of diabetic glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Histology of human tubulo-interstitial nephritis associated with antibodies to renal basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

D-Penicillamine Induced Goodpasture's Syndrome in Wilson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Conversion of Goodpasture's syndrome into membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Plasma exchange in Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Complete recovery of renal function in a dialysis-dependent patient with Goodpasture syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Immunoadsorption in Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Recurrent crescentic glomerulonephritis in renal transplant recipient treated with cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Late recurrence of systemic vasculitis after kidney transplantation involving the kidney allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Recurrence of Wegener's granulomatosis following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Pulmonary renal syndrome: a 4-year, single-center experience

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Use of testosterone to prevent cyclophosphamide-induced azoospermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Recurrent Goodpasture's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900029-5

7 January 2021

10.1016/S0749-0704(02)00029-5

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12418445